Skip to main content

Table 6 Percentage antimalarial activities across the groups

From: Solubility enhancing lipid-based vehicles for artemether and lumefantrine destined for the possible treatment of induced malaria and inflammation: in vitro and in vivo evaluations

Groups

Antimalarial activity (%)

Group A

56.36

Group B

43.05

Group C

72.63

Group D

77.07

Group E

84.23

Group F

85.21

Group G

55.03

Group H

–

Group I

–

Group J

–

Group K

15.18

Group L

20.12

Group M

–

Group N

–

Group P

21.20